Literature DB >> 19026158

Neuroprotective effect of sodium ferulate and signal transduction mechanisms in the aged rat hippocampus.

Ying Jin1, En-zhi Yan, Xiao-ming Li, Ying Fan, Yan-jie Zhao, Zhuo Liu, Wan-zhu Liu.   

Abstract

AIM: To investigate whether the age-related increase in interleukin-1beta (IL-1beta) and c-Jun N-terminal kinases (JNK) pathway was coupled with a decrease in cell survival signaling pathways and whether sodium ferulate (SF) treatment was effective in preventing these age-associated changes.
METHODS: Groups of young and aged rats were fed for 4 weeks on a diet enriched in SF (100 mg/kg and 200 mg/kg per day). At the end of the period of dietary manipulation, Western blotting analysis was used to determine the expressions of IL-1beta, phosphorylated mitogen-activated protein kinase kinase (MKK)4, phospho-JNK, phospho-c-Jun, phosphorylated extracellular signal-regulated kinase (ERK1/2), phospho-MEK, phospho-Akt, phosphorylated ribosomal protein S6 protein kinase (p70S6K), and activated caspase-3 and caspase-7. Nissl staining was used to observe the morphological change in hippocampal CA1 regions. Immunohistochemical techniques for glial fibrillary acidic protein (GFAP) and integrin alphaM (OX-42) were used to determine the astrocyte and microglia activation.
RESULTS: IL-1beta protein levels, and phospho-MKK4, phospho-JNK1/2, and phospho-c-Jun were significantly enhanced in hippocampus prepared from age-matched control rats. Increased IL-1beta production and JNK1/2 activation was accompanied by downregulation of MEK/ERK1/2 pathway and Akt/p70S6K pathway, leading to cell apoptosis assessed by activation of caspase-3. Significantly, treatment of aged rats with SF (100 mg/kg and 200 mg/kg per day) for 4 weeks prevented the agerelated increase in IL-1beta and IL-1beta-induced JNK signaling pathway and also the age-related changes in ERK and Akt kinase.
CONCLUSION: SF plays neuroprotective roles through suppression of IL-1beta and IL-1beta-induced JNK signaling and upregulation of MEK/ERK1/2 and Akt/p70S6K survival pathways.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19026158     DOI: 10.1111/j.1745-7254.2008.00848.x

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  6 in total

1.  Attenuation of age-related changes in FOXO3a activity and the PI3K/Akt pathway by short-term feeding of ferulate.

Authors:  Yeon Ja Choi; Dae Hyun Kim; Eun Kyeong Lee; Ji Min Kim; Young Mi Ha; Nam Deuk Kim; Jee H Jung; Jae Sue Choi; Byung Pal Yu; Hae Young Chung
Journal:  Age (Dordr)       Date:  2011-04-06

2.  Photobiomodulation Improves the Inflammatory Response and Intracellular Signaling Proteins Linked to Vascular Function and Cell Survival in the Brain of Aged Rats.

Authors:  Fabrízio Dos Santos Cardoso; Fernanda Cristina Borini Mansur; Bruno Henrique Silva Araújo; F Gonzalez-Lima; Sérgio Gomes da Silva
Journal:  Mol Neurobiol       Date:  2021-10-27       Impact factor: 5.682

3.  JNK contributes to Hif-1alpha regulation in hypoxic neurons.

Authors:  Xanthi Antoniou; Alessandra Sclip; Cristina Ploia; Alessio Colombo; Gautier Moroy; Tiziana Borsello
Journal:  Molecules       Date:  2009-12-30       Impact factor: 4.411

4.  Therapeutic effects of dietary intervention on neuroinflammation and brain metabolism in a rat model of photothrombotic stroke.

Authors:  Ewelina Kurtys; Cindy Casteels; Caroline C Real; Ulrich L M Eisel; J Martin Verkuyl; Laus M Broersen; Hans C Klein; Rudi A J O Dierckx; Janine Doorduin; Erik F J de Vries
Journal:  CNS Neurosci Ther       Date:  2018-05-27       Impact factor: 5.243

5.  Ferulic Acid Administered at Various Time Points Protects against Cerebral Infarction by Activating p38 MAPK/p90RSK/CREB/Bcl-2 Anti-Apoptotic Signaling in the Subacute Phase of Cerebral Ischemia-Reperfusion Injury in Rats.

Authors:  Chin-Yi Cheng; Nou-Ying Tang; Shung-Te Kao; Ching-Liang Hsieh
Journal:  PLoS One       Date:  2016-05-17       Impact factor: 3.240

6.  Neuroprotective potential of ferulic acid in the rotenone model of Parkinson's disease.

Authors:  Shreesh Ojha; Hayate Javed; Sheikh Azimullah; Salema B Abul Khair; M Emdadul Haque
Journal:  Drug Des Devel Ther       Date:  2015-10-07       Impact factor: 4.162

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.